GSK EBITDA 2010-2024 | GSK
- GSK 2023 EBITDA was 11.244B, a 5.95% increase from 2022.
- GSK 2022 EBITDA was 10.613B, a 24.46% increase from 2021.
- GSK 2021 EBITDA was 8.527B, a 34.47% decline from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.